Ultragenyx Company Insiders

RARE Stock  USD 46.02  0.38  0.82%   
Ultragenyx's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Ultragenyx suggests that all insiders are panicking. Ultragenyx employs about 1.3 K people. The company is managed by 18 executives with a total tenure of roughly 21 years, averaging almost 1.0 years of service per executive, having 70.89 employees per reported executive.
Erik Harris  President
Executive Vice President and Chief Commercial Officer

Ultragenyx's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-10-10Howard HornDisposed 7465 @ 52.76View
2024-09-03Theodore Alan HuizengaDisposed 91 @ 56.19View
2024-08-06Emil D KakkisDisposed 20000 @ 50.17View
2024-07-02Corazon (Corsee) D SandersDisposed 584 @ 40.98View
2024-06-12Karah Herdman ParschauerDisposed 9806 @ 45View
2024-06-10Corazon (Corsee) D SandersDisposed 1737 @ 41.1View
2024-04-18Eric CrombezDisposed 142 @ 44.1View
2024-03-11Thomas Richard KassbergDisposed 11509 @ 49.93View
2024-03-07Matthew K FustDisposed 12195 @ 50.88View
2024-03-01John Richard PinionDisposed 4173 @ 53.76View
Monitoring Ultragenyx's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ultragenyx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.

Ultragenyx's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Ultragenyx's future performance. Based on our forecasts, it is anticipated that Ultragenyx will maintain a workforce of about 1280 employees by December 2024.
 
Yuan Drop
 
Covid

Ultragenyx Management Team Effectiveness

The company has return on total asset (ROA) of (0.2412) % which means that it has lost $0.2412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.8998) %, meaning that it created substantial loss on money invested by shareholders. Ultragenyx's management efficiency ratios could be used to measure how well Ultragenyx manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.5. In addition to that, Return On Capital Employed is expected to decline to -0.49. At present, Ultragenyx's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 20.3 M, whereas Other Current Assets are forecasted to decline to about 34.5 M.
As of November 22, 2024, Common Stock Shares Outstanding is expected to decline to about 50.9 M. The current year's Net Loss is expected to grow to about (604.8 M)

Ultragenyx Workforce Comparison

Ultragenyx is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 10,610. Ultragenyx retains roughly 1,276 in number of employees claiming about 12% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.95) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.95.

Ultragenyx Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ultragenyx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ultragenyx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Ultragenyx insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
0.25
1
4
 700.00 
 40,675 
2024-06-01
2.8
14
5
 106,715 
 12,053 
2024-03-01
1.5882
27
17
 503,891 
 90,333 
2023-12-01
1.0
5
5
 309,566 
 205,462 
2023-09-01
0.5
3
6
 6,702 
 11,133 
2023-06-01
1.0625
17
16
 92,810 
 64,250 
2023-03-01
1.6154
21
13
 479,104 
 53,037 
2022-06-01
12.5
25
2
 134,720 
 427.00 
2022-03-01
1.6
24
15
 627,271 
 64,563 
2021-09-01
0.3333
3
9
 119,570 
 135,600 
2021-06-01
1.125
18
16
 61,540 
 46,194 
2021-03-01
1.4
28
20
 255,484 
 183,032 
2020-12-01
0.3158
6
19
 110,000 
 95,746 
2020-09-01
0.4483
13
29
 76,038 
 220,039 
2020-06-01
0.4894
23
47
 102,919 
 138,707 
2020-03-01
2.6364
29
11
 482,718 
 86,803 
2019-12-01
9.0
9
1
 14,050 
 1,297 
2019-09-01
0.75
3
4
 36,843 
 32,752 
2019-06-01
1.0
26
26
 92,343 
 58,861 
2019-03-01
1.8
36
20
 593,408 
 71,909 
2018-12-01
0.75
3
4
 102,000 
 30,000 
2018-09-01
0.2857
2
7
 8,350 
 29,449 
2018-06-01
1.0417
25
24
 81,619 
 50,525 
2018-03-01
2.1111
19
9
 463,288 
 14,555 
2017-09-01
1.0
2
2
 7,500 
 1,645 
2017-06-01
1.1538
15
13
 54,375 
 6,598 
2017-03-01
3.6
18
5
 268,725 
 50,500 
2016-12-01
0.2083
5
24
 50,500 
 134,500 
2016-06-01
1.6842
32
19
 365,050 
 46,310 
2016-03-01
0.375
3
8
 17,000 
 5,125 
2015-12-01
0.0769
2
26
 13,500 
 90,125 
2015-09-01
0.3
6
20
 222,500 
 48,318 
2015-06-01
1.5
21
14
 310,800 
 40,001 
2015-03-01
0.3333
3
9
 26,319 
 30,818 
2014-12-01
0.1111
1
9
 29,108 
 57,107 
2014-09-01
0.8571
6
7
 205,000 
 2,322,399 
2014-03-01
0.7917
19
24
 7,343,502 
 24,803,067 
2007-09-01
1.0
6
6
 59,487 
 59,487 
2007-03-01
0.6471
11
17
 115,567 
 137,147 
2006-06-01
0.1667
2
12
 20,000 
 40,000 
2006-03-01
1.1818
13
11
 176,463 
 77,090 
2005-12-01
0.1538
2
13
 25,569 
 53,138 
2005-09-01
0.25
1
4
 20,000 
 40,000 
2005-06-01
0.2727
3
11
 39,293 
 78,586 
2005-03-01
1.2
6
5
 98,762 
 60,000 
2004-12-01
0.2
2
10
 25,000 
 50,000 
2004-09-01
0.7273
8
11
 87,785 
 70,570 
2004-06-01
0.2
1
5
 10,000 
 25,000 
2004-03-01
1.125
9
8
 95,498 
 115,998 

Ultragenyx Notable Stakeholders

An Ultragenyx stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ultragenyx often face trade-offs trying to please all of them. Ultragenyx's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ultragenyx's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Erik HarrisExecutive Vice President and Chief Commercial OfficerProfile
Howard HornExecutive CFOProfile
Dennis HuangChief Technical Operations Officer and Sr. VPProfile
Thomas KassbergChief Bus. Officer and Sr. VPProfile
Theodore HuizengaCorporate VPProfile
Eric MDChief VPProfile
Arjun NatesanVice ResearchProfile
Vimal SrivastavaSenior ManagementProfile
Aaron OlsenSenior FinanceProfile
Paul JDVice PropertyProfile
Camille MDChief VPProfile
Erik MBAExecutive OfficerProfile
Alison SkrinarVice EvaluationProfile
Danielle KeatleySenior CommunicationsProfile
Samuel WadsworthChief TherapyProfile
Ernie MeyerChief VPProfile
Karah JDChief AffairsProfile
John IIChief SciencesProfile

About Ultragenyx Management Performance

The success or failure of an entity such as Ultragenyx often depends on how effective the management is. Ultragenyx management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ultragenyx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ultragenyx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.47)(0.50)
Return On Capital Employed(0.47)(0.49)
Return On Assets(0.41)(0.43)
Return On Equity(2.20)(2.09)
Please note, the presentation of Ultragenyx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ultragenyx's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ultragenyx's management manipulating its earnings.

Ultragenyx Workforce Analysis

Traditionally, organizations such as Ultragenyx use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ultragenyx within its industry.

Ultragenyx Manpower Efficiency

Return on Ultragenyx Manpower

Revenue Per Employee340.3K
Revenue Per Executive24.1M
Net Loss Per Employee475.4K
Net Loss Per Executive33.7M
Working Capital Per Employee354K
Working Capital Per Executive25.1M

Complementary Tools for Ultragenyx Stock analysis

When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing